Richter's Transformation after CD-19 Directed CAR-T Cells for Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL)

被引：2
|
作者：
Blackmon, Amanda [1 ]
Danilov, Alexey V. [2 ]
Wang, Lili [3 ]
Pillai, Raju [4 ]
Mirshkarlo, Hormoz Babaei [5 ]
Rosen, Steven T. [6 ]
Siddiqi, Tanya [1 ]
机构：
[1] City Hope Natl Med Ctr, Dept Hematol & Hematopoiet Cell Transplantat, Duarte, CA USA
[2] City Hope Comprehens Canc Ctr, Duarte, CA USA
[3] City Hope Natl Med Ctr, Beckman Res Inst, Dept Syst Biol, Monrovia, CA USA
[4] City Hope Natl Med Ctr, Dept Pathol, Duarte, CA USA
[5] City Hope Natl Med Ctr, Duarte, CA USA
[6] City Hope Natl Med Ctr, Dept Hematol & Hematopoiet Cell Transplantat, Duarte, CA USA
来源：
BLOOD | 2021年 / 138卷
关键词：
D O I：
10.1182/blood-2021-149815
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1430
引用
收藏
页数：4
相关论文
共 50 条
  • [31] Humanized CD19 CAR-T cells in relapsed/refractory B-ALL patients who relapsed after or failed murine CD19 CART therapy
    An, Lihong
    Lin, Yuehui
    Deng, Biping
    Yin, Zhichao
    Zhao, Defeng
    Ling, Zhuojun
    Wu, Tong
    Zhao, Yongqiang
    Chang, Alex H.
    Tong, Chunrong
    Liu, Shuangyou
    BMC CANCER, 2022, 22 (01)
  • [32] Outcomes of Richter’s transformation of chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL): an analysis of the SEER database
    Radowan Elnair
    Moataz Ellithi
    Avyakta Kallam
    Valerie Shostrom
    Robert G. Bociek
    Annals of Hematology, 2021, 100 : 2513 - 2519
  • [33] A Phase I Clinical Trial of CLL-1 CAR-T Cells for the Treatment of Relapsed/Refractory Acute Myeloid Leukemia in Adults
    Zhang, Xiaomei
    Lv, Hairong
    Xiao, Xia
    Bai, Xue
    Liu, Pengjiang
    Pu, Yedi
    Meng, Juanxia
    Zhu, Haibo
    Wang, Zhao
    Zhang, Huan
    Zhang, Yu
    Lv, Cuicui
    Ma, Li
    Yuan, Ting
    Zhang, Meng
    Sun, Rui
    Zhao, Yifan
    Cao, Xinping
    Guo, Ruiting
    Zhang, Yi
    Guo, Shujing
    Liu, Jile
    Zhao, Mingfeng
    BLOOD, 2023, 142
  • [34] Isolated Richter's transformation in central nervous system in a patient with refractory chronic lymphocytic leukemia
    Cetintepe, Tugba
    Kobak, Fusun Gediz
    Bener, Sadi
    INDIAN JOURNAL OF CANCER, 2021, 58 (03) : 428 - 430
  • [35] Evolution and Proliferation of CD7 CAR-T Cells Compared to CD19 CAR-T Cells Therapies for Acute Leukemia
    Zhang, Xian
    Zhang, Gailing
    Li, Wenqian
    Qiu, Liyuan
    Wang, Dongchu
    Yang, Junfang
    Li, Jingjing
    Lu, Peihua
    BLOOD, 2021, 138
  • [36] Anti-CD22 CAR-T Cell Therapy as a Salvage Treatment in B Cell Malignancies Refractory or Relapsed After Anti-CD19 CAR-T therapy
    Zhu, Haibo
    Deng, Haobin
    Mu, Juan
    Lyu, Cuicui
    Jiang, Yanyu
    Deng, Qi
    ONCOTARGETS AND THERAPY, 2021, 14 : 4023 - 4037
  • [37] Patient-reported outcomes in CD30-directed CAR-T cells against relapsed/refractory CD30+lymphomas
    Tschernia, Nicholas P.
    Heiling, Hillary
    Deal, Allison M.
    Cheng, Catherine
    Babinec, Caroline
    Gonzalez, Megan
    Morrison, J. Kaitlin
    Dittus, Christopher
    Dotti, Gianpietro
    Beaven, Anne W.
    Serody, Jonathan S.
    Wood, William A.
    Savoldo, Barbara
    Grover, Natalie S.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2023, 11 (08)
  • [38] 3RD-GENERATION CD19-DIRECTED CHIMERIC ANTIGEN RECEPTOR T-CELLS (CARTS) FOR RELAPSED/REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) - UPDATE ON THE ONGOING ACADEMIC PHASE 1/2 TRIAL (HD-CAR-1)
    Derigs, P.
    Kunz, A.
    Dreger, P.
    Schmitt, A.
    Schubert, M. -L.
    Brueggemann, M.
    Bernhard, H.
    Kobbe, G.
    Lindemann, A.
    Rummel, M.
    Wang, L.
    Michels, B.
    Waldhoff, P.
    Korell, F.
    Laier, S.
    Ho, A. D.
    Mueller-Tidow, C.
    Schmitt, M.
    HUMAN GENE THERAPY, 2023, 34 (21-22) : A7 - A8
  • [39] 3rd-generation CD19-directed chimeric antigen receptor t-cells (carts) for relapsed/refractory chronic lymphocytic leukemia (cll) - results from an academic phase 1/2 trial (hd-car-1)
    Derigs, P.
    Kunz, A.
    Dreger, P.
    Schmitt, A.
    Schubert, M. -L.
    Brueggemann, M.
    Bernhard, H.
    Kobbe, G.
    Lindemann, A.
    Rummel, M.
    Wang, L.
    Michels, B.
    Waldhoff, P.
    Korell, F.
    Pavel, P.
    Ho, A. D.
    Muller-Tidow, C.
    Schmitt, M.
    BONE MARROW TRANSPLANTATION, 2022, 57 (SUPPL 1) : 129 - 130
  • [40] CD19-specific car-t cells for the treatment of cns chloromas in children with relapsed/refractory b-cell acute lymphoblastic leukemia
    Shahid, S.
    Cancio, M.
    Haque, S. S.
    Khakoo, Y.
    McWilliams, E.
    Santomasso, B. D.
    Scaradavou, A.
    Spitzer, B.
    Wolden, S. L.
    Boelens, J. J.
    Curran, K. J.
    BONE MARROW TRANSPLANTATION, 2022, 57 (SUPPL 1) : 137 - 138
12345